secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001628280-24-028097
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera shareholders elect directors, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------

- Class I directors Véronique Lecault and Andrew Lo elected with 167M and 152M votes for, respectively.
- Ratification of KPMG as auditor for FY 2024 approved: 212M for, 0.3M against, 0.4M abstain.
- Non-binding advisory vote on executive compensation approved: 176.6M for, 7.5M against, 5.2M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000162828024028097/0001628280-24-028097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000162828024028097/abcl-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-028097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer